Renal replacement therapy among disadvantaged populations in Mexico: A report from the Jalisco Dialysis and Transplant Registry (REDTJAL)

被引:50
|
作者
Garcia-Garcia, G [1 ]
Monteon-Ramos, IF [1 ]
Garcia-Bejarano, H [1 ]
Gomez-Navarro, B [1 ]
Hernandez-Reyes, I [1 ]
Lomeli, AM [1 ]
Palomeque, M [1 ]
Cortes-Sanabria, L [1 ]
Breien-Alcaraz, H [1 ]
Ruiz-Morales, NM [1 ]
机构
[1] Hosp Civil Guadalajara Apdo, Jalisco Dialyisis & Transplant Registry, Guadalajara 44281, Jalisco, Mexico
关键词
dialysis; access; insurance; transplant; poverty;
D O I
10.1111/j.1523-1755.2005.09710.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background. End-stage renal disease represents a serious public health problem in Jalisco, Mexico. It is reported among the 10 leading causes of death, with an annual mortality rate of 12 deaths per 100,000 population. The state population is 6.3 million, and more than half do not have medical insurance. In this study, we report the population's access to renal replacement therapy (RRT). Methods. Patients >= 15 years of age, who started RRT between January 1998 and December 2000 at social security or health secretariat medical facilities, were included. Nine facilities participated in the study. At the start of treatment, the patient's facility, age, gender, cause of renal failure, and initial treatment modality were registered. Results. Within the study period, 2456 started RRT, 1767 (72%) at social security facilities and 687 (28%) at health secretariat facilities, for an annual incidence rate of 195 per million population (pmp). The main cause of renal failure was diabetes mellitus (51% of patients). There were significant differences between the 2 populations. Patients with social security were older (53.1 +/- 17 vs. 45.1 +/- 20 years, P = 0.001) and had more diabetes (54% vs. 42%, P 0.001) than those without social security. They had higher acceptance (327 pmp vs. 99 pmp, P = 0.001) and prevalence rates (939 pmp vs. 166 pmp, P = 0.001) than patients without medical insurance. Dialysis use was similar in both populations. Eighty-five percent of patients were on continuous ambulatory peritoneal dialysis and 15% on hemodialysis. Kidney transplant rate was higher among insured patients (72 pmp vs. 7.5 pmp, P = 0.001). The number of dialysis programs and nephrologists that offered renal care also differed. There were 10 dialysis programs in social security and 3 in health secretariat facilities. Fourteen nephrologists looked after the insured population, whereas 5 cared for the uninsured (7.7 pmp vs. 2.1 pmp, P = 0.001). The latter had access to 8 hemodialysis stations compared with 34 for the insured population (3.4 pmp vs. 18.8 pmp, P = 0.001). Conclusions. Access to RRT is unequal in our state. Although it is universal for the insured population, it is severely restricted for the poor. Social and economical factors, as well as the limited number of understaffed, centralized dialysis facilities, could explain these differences.
引用
收藏
页码:S58 / S61
页数:4
相关论文
共 50 条
  • [31] UK Renal Registry 20th Annual Report: Chapter 5 Survival and Cause of Death in UK Adult Patients on Renal Replacement Therapy in 2016: National and Centre-specific Analyses
    Steenkamp, Retha
    Pyart, Rhodri
    Fraser, Simon
    NEPHRON, 2018, 139 : 117 - 149
  • [32] UK Renal Registry 19th Annual Report: Chapter 2 UK Renal Replacement Therapy Prevalence in 2015: National and Centre-specific Analyses
    MacNeill, Stephanie J.
    Ford, Daniel
    NEPHRON, 2017, 137 : 45 - 71
  • [33] UK Renal Registry 18th Annual Report: Chapter 1 UK Renal Replacement Therapy Incidence in 2014: National and Centre-specific Analyses
    Gilg, Julie
    Caskey, Fergus
    Fogarty, Damian
    NEPHRON, 2016, 132 : 9 - 39
  • [34] UK Renal Registry 16th Annual Report: Chapter 1 UK Renal Replacement Therapy Incidence in 2012: National and Centre- specific Analyses
    Gilg, Julie
    Rao, Anirudh
    Fogarty, Damian
    NEPHRON CLINICAL PRACTICE, 2013, 125 (1-4): : 1 - 27
  • [35] UK Renal Registry 17th Annual Report: Chapter 1 UK Renal Replacement Therapy Incidence in 2013: National and Centre-specific Analyses
    Gilg, Julie
    Pruthi, Rishi
    Fogarty, Damian
    NEPHRON, 2015, 129 : 1 - 29
  • [36] UK Renal Registry 17th Annual Report: Chapter 2 UK Renal Replacement Therapy Prevalence in 2013: National and Centre-specific Analyses
    Rao, Anirudh
    Casula, Anna
    Castledine, Clare
    NEPHRON, 2015, 129 : 31 - 56
  • [37] Peritoneal dialysis catheter placement as a mode of renal replacement therapy: Long-term results from a tertiary academic institution
    Haskins, Ivy N.
    Schreiber, Martin, Jr.
    Prabhu, Ajita S.
    Krpata, David M.
    Perez, Arielle J.
    Tastaldi, Luciano
    Tu, Chao
    Rosen, Michael J.
    Rosenblatt, Steven
    SURGERY, 2017, 162 (05) : 1112 - 1120
  • [38] UK Renal Registry 18th Annual Report: Chapter 2 UK Renal Replacement Therapy Prevalence in 2014: National and Centre-specific Analyses
    MacNeill, Stephanie J.
    Casula, Anna
    Shaw, Catriona
    Castledine, Clare
    NEPHRON, 2016, 132 : 41 - 67
  • [39] UK Renal Registry 12th Annual Report (December 2009): Chapter 7 Survival and Causes of Death of UK Adult Patients on Renal Replacement Therapy in 2008: national and centre-specific analyses
    Ansell, David
    Roderick, Paul
    Steenkamp, Retha
    Tomson, Charles R. V.
    NEPHRON CLINICAL PRACTICE, 2010, 115 : C117 - C144
  • [40] UK Renal Registry 13th Annual Report (December 2010): Chapter 6 Survival and Causes of Death of UK Adult Patients on Renal Replacement Therapy in 2009: National and Centre-Specific Analyses
    Castledine, Clare
    Steenkamp, Retha
    Feest, Terry
    Tomson, Charles R. V.
    NEPHRON CLINICAL PRACTICE, 2011, 119 : C107 - C134